Edition:
United Kingdom

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

3.60USD
8:59pm GMT
Change (% chg)

$-0.31 (-7.81%)
Prev Close
$3.90
Open
$3.98
Day's High
$3.98
Day's Low
$3.56
Volume
4,875
Avg. Vol
2,019
52-wk High
$12.59
52-wk Low
$3.56

Latest Key Developments (Source: Significant Developments)

Tenax Therapeutics Files For Mixed Shelf Of Up To $75 Mln
Tuesday, 15 May 2018 

May 15 (Reuters) - Tenax Therapeutics Inc ::TENAX THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $75 MILLION – SEC FILING.  Full Article

Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Tenax Therapeutics Inc ::TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES.TENAX THERAPEUTICS - PHASE 2 TRIAL TO INVESTIGATE LEVOSIMENDAN IN PULMONARY HYPERTENSION-WHO GROUP 2 PATIENTS WITH PRESERVED EJECTION FRACTION.TENAX THERAPEUTICS INC - PLANS TO INITIATE PHASE 2 TRIAL IN PH-HFPEF PATIENTS IN EARLY PART OF Q3 OF 2018.TENAX THERAPEUTICS INC - ‍PRE-IND MEETING IS SCHEDULED WITH FDA TO DISCUSS DEVELOPMENT OF LEVOSIMENDAN IN PH-HFPEF IN COMING MONTHS​.  Full Article